Mariana de Mendonca
Overview
Explore the profile of Mariana de Mendonca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fuller O, McLennan E, Egan C, Perera N, Terry L, Pyun J, et al.
iScience
. 2025 Feb;
28(2):111752.
PMID: 39898049
Exercise improves cognitive function in Alzheimer's disease (AD) via mechanism that are not fully clear. Here, we first examined the effect of voluntary exercise training (VET) on energy metabolism and...
2.
de Sousa E, de Mendonca M, Bolin A, de Oliveira N, Real C, Hu X, et al.
Biochim Biophys Acta Mol Basis Dis
. 2024 Feb;
1870(4):167057.
PMID: 38331111
During inguinal adipose tissue (iWAT) ontogenesis, beige adipocytes spontaneously appear between postnatal 10 (P10) and P20 and their ablation impairs iWAT browning capacity in adulthood. Since maternal obesity has deleterious...
3.
Rodrigues A, Spagnol A, Frias F, de Mendonca M, Araujo H, Guimaraes D, et al.
Front Physiol
. 2021 Jul;
12:676265.
PMID: 34295259
The role of microRNAs in metabolic diseases has been recognized and modulation of them could be a promising strategy to treat obesity and obesity-related diseases. The major purpose of this...
4.
de Mendonca M, Rocha K, de Sousa E, Pereira B, Oyama L, Rodrigues A
Am J Physiol Endocrinol Metab
. 2020 Aug;
319(3):E579-E591.
PMID: 32744099
There is a growing body of evidence that extracellular vesicles (EVs) and their cargo of RNA, DNA, and protein are released in the circulation with exercise and might mediate interorgan...
5.
de Mendonca M, de Sousa E, da Paixao A, Dos Santos B, Roveratti Spagnol A, Murata G, et al.
Mol Cell Endocrinol
. 2019 Nov;
501:110661.
PMID: 31770568
Pioglitazone belongs to the class of drugs thiazolidinediones (TZDs) and is an oral hypoglycemic drug, used in the treatment of type 2 diabetes, which improves insulin sensitivity in target tissues....
6.
de Mendonca M, Dos Santos B, de Sousa E, Rodrigues A
Mol Cell Endocrinol
. 2019 Jun;
493:110480.
PMID: 31176759
Pioglitazone has been used for the treatment of nonalcoholic fatty liver disease (NAFLD) related to diabetes. The role of adiponectin in pioglitazone-induced improvements in NAFLD was studied by using wild-type...
7.
Frias F, Rocha K, de Mendonca M, Murata G, Araujo H, de Sousa L, et al.
J Cell Physiol
. 2017 Sep;
233(4):3515-3528.
PMID: 28926107
The effect of fenofibrate on the metabolism of skeletal muscle and visceral white adipose tissue of diet-induced obese (DIO) mice was investigated. C57BL/6J male mice were fed either a control...
8.
Frias F, de Mendonca M, Martins A, Gindro A, Cogliati B, Curi R, et al.
Front Endocrinol (Lausanne)
. 2016 Jul;
7:76.
PMID: 27445979
High-fat diet (HFD) feeding causes insulin resistance (IR) in skeletal muscle of mice, which affects skeletal muscle metabolism and function. The involvement of muscle-specific microRNAs in the evolution of skeletal...